Pandemic hurts sales, profit for Pfizer amid restructuring
Drugmaker Pfizer on Tuesday reported a 32% plunge in second-quarter profit, as the global coronavirus pandemic limited marketing of new prescriptions for its medicines
Drugmaker Pfizer on Tuesday reported a 32% plunge in second-quarter profit, as the global coronavirus pandemic limited marketing of new prescriptions for its medicines